MoneyWorks4Me

Astrazeneca Pharma India informs about loss of share certificate

02 Jan 2020 Evaluate

Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, Astrazeneca Pharma India has informed that the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate as per attached details.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..